Rentokil Initial (RTO) AI Stock Analysis

• Market Cap: $15.57B
• Dividend Yield: 2.2%
• Average Volume (3M): 792.30K
• Price to Earnings (P/E): 31.6
• Beta (1Y): 0.75
• Revenue Growth: 1.56%
• EPS Growth: -32.50%
• Country: US
• Employees: 68,485
• Sector: Industrials
• Sector Strength: 72
• Industry: Specialty Business Services
• EPS (TTM): 0.65
• Shares Outstanding: 505,207,980
• 10 Day Avg. Volume: 681,139
• 30 Day Avg. Volume: 792,301
• PEG Ratio: 1.89
• Price to Book (P/B): 2.71
• Price to Sales (P/S): 2.15
• P/FCF Ratio: 19.29
• Enterprise Value/Market Cap: 0.93
• Enterprise Value/Revenue: 2.42
• Enterprise Value/Gross Profit: 17.72
• Enterprise Value/Ebitda: 12.36
• 1Y Price Target: $35.00
• Price Target Upside: 6.84% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1
• EPS Forecast (FY): 1.44
• Revenue Forecast (FY): $7.24B

• Rating: 60 Neutral
• Price Target: $33.00 ▲(0.73% Upside)
• Action: Reiterated Date: 03/07/26
• Date: Action: Reiterated 03/07/26

The score is driven primarily by steady underlying profitability and consistent free cash flow, reinforced by constructive (though not flawless) earnings-call signals around cash conversion, leverage improvement, and cost savings. Offsetting these are the recent top-line contraction and balance-sheet leverage constraints, alongside a relatively expensive valuation and mixed technical momentum (negative MACD).

Positive Factors

Resilient EBITDA margins

Sustained EBITDA margins near 18–22% indicate a durable ability to convert revenue into operating profit. For a services business with subscription contracts, stable margins support reinvestment, fund capex/M&A and provide a cushion against cyclical revenue swings over the next 2–6 months.

Very strong free cash flow conversion

Near‑100% FCF conversion and rising absolute free cash flow strengthen internal funding for dividends, bolt‑on M&A and branch expansion. The cash profile materially improves balance sheet repair and supports management’s plan to reduce net debt/EBITDA toward 2.0–2.5x, enhancing financial flexibility.

Technology and local growth strategy

Scale in IoT devices and internal AI deployments increase lead conversion, technician productivity and recurring revenue visibility. Combined with branch/brand expansion, these structural investments should lift local market share, improve unit economics and sustain growth drivers beyond short-term cycles.

Negative Factors

Recent sharp revenue drop

A large top‑line contraction weakens the revenue base that underpins recurring contract economics and margin absorption. If the decline persists it will constrain reinvestment capacity, slow deleveraging and force heavier reliance on cost cuts or M&A to restore growth over the medium term.

Material leverage on the balance sheet

A capital structure that meaningfully uses debt limits headroom for additional borrowing and amplifies sensitivity to cash shocks. Elevated leverage reduces strategic flexibility for larger acquisitions or prolonged operating weakness and increases refinancing and interest‑rate exposure risk.

Large termite provisions and one-off cash outflows

Substantial litigation provisions and recurring termite settlements impose persistent cash burdens and raise provisioning assumptions. These structural outflows can erode free cash flow, divert capital from growth initiatives, and create earnings volatility until legal exposures and claim trends subside.

Rentokil Initial Business Overview & Revenue Model

Company Description

Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial and residential customers. The company also provides hygiene services, including the provision and maintenance of products, such as soap and hand sanitizer dispensers, hand dryers, air care and purification, cubicle and surface sanitizers, feminine hygiene units, toilet paper dispensers, and floor protection mats. In addition, it engages in the supply and laundering of workwear, uniforms, cleanroom uniforms, and protective equipment. Further, the company installs and services interior and exterior plant displays, flowers, replica foliage, Christmas decorations, and ambient scenting for commercial businesses; offers property care services consisting of damp proofing, property conservation, and woodworm and wood rot treatment; and provides a range of specialist cleaning services, such as graffiti removal deep cleaning of kitchens and washrooms, trauma cleaning, and flood or fire damage cleaning, as well as specialist industrial cleaning and disinfection services, including the professional and discreet disinfection of areas that have been exposed to bio-hazardous situations, such as crime and trauma scenes, prison cells, void properties, emergency vehicles, and healthcare establishments. Additionally, it offers a range of healthcare waste management services comprising the collection, disposal, and recycling of hazardous and offensive waste produced by businesses and organizations associated with the provision of healthcare; and color-coded sharps disposal bins to deal with various types of waste. Rentokil Initial plc was founded in 1903 and is headquartered in Crawley, the United Kingdom.

How the Company Makes Money

Rentokil Initial generates revenue through multiple streams, primarily from its pest control and hygiene service contracts. The company charges clients on a subscription basis for ongoing pest management services, which includes regular inspections, treatments, and preventative measures. Additionally, Rentokil Initial earns income from one-off services such as pest eradication and hygiene product sales. Strategic partnerships with businesses in various industries, such as food production and healthcare, enhance its service offerings and expand its customer base. Furthermore, the company's focus on innovation, including the development of smart pest control technologies, positions it to capture additional market share and drive revenue growth.

Rentokil Initial Financial Statement Overview

Summary

Steady profitability (EBITDA margins ~18%–22%) and consistently positive free cash flow support the core financial profile, but the latest period’s sharp revenue decline (-15.7% in 2025 vs. 2024), moderate debt coverage from operating cash flow, and leverage (~1.0–1.3 debt-to-equity) reduce flexibility if growth stays pressured.

Income Statement

Profitability is steady with net margins generally in the mid-to-high single digits (about 5.6%–8.9%) and EBITDA margins holding near ~18%–22% over the period, which suggests a reasonably resilient earnings model. That said, the latest annual period shows a meaningful revenue decline (-15.7% in 2025 vs. 2024), creating a weaker near-term growth profile and raising questions about the durability of recent demand/pricing. Overall, earnings quality looks acceptable, but the sharp top-line contraction in the most recent year is a clear offset.

Balance Sheet

Leverage is the main constraint: debt-to-equity sits around ~1.0–1.3 in recent years (and was higher in 2020), indicating a balance sheet that relies materially on debt financing. Returns on equity are moderate (roughly ~5.7%–9.3% in 2022–2025, with a higher outlier in 2021), implying decent but not exceptional value creation given the leverage. Asset base is large and stable, but the capital structure leaves less room for error if operating performance softens.

Cash Flow

Cash generation is consistently positive, with free cash flow positive every year and typically covering a substantial portion of net income (about ~0.69–0.79x). However, free cash flow growth has turned negative recently (down in 2024 and 2025), and operating cash flow relative to the company’s debt load appears modest (coverage in the ~0.21–0.30 range recently), which can limit deleveraging speed. Overall: solid ongoing cash conversion, but weakening momentum and only moderate debt-carrying comfort from operating cash flow.

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	5.14B	5.44B	5.38B	3.71B	2.95B
Gross Profit	702.98M	726.00M	4.45B	977.00M	714.80M
EBITDA	1.12B	990.00M	1.16B	748.00M	580.00M
Net Income	349.63M	307.00M	381.00M	232.00M	263.00M
Balance Sheet
Total Assets	10.71B	10.55B	11.13B	11.92B	4.32B
Cash, Cash Equivalents and Short-Term Investments	1.72B	927.00M	1.55B	2.17B	670.00M
Total Debt	4.55B	4.14B	4.73B	5.47B	1.97B
Total Liabilities	6.63B	6.33B	7.04B	7.82B	3.06B
Stockholders Equity	4.08B	4.23B	4.09B	4.10B	1.26B
Cash Flow
Free Cash Flow	572.05M	507.00M	526.00M	414.00M	407.20M
Operating Cash Flow	726.78M	678.00M	737.00M	604.00M	567.10M
Investing Cash Flow	15.62M	-373.00M	-416.00M	-1.20B	-441.00M
Financing Cash Flow	20.09M	-752.00M	-361.00M	1.32B	-417.10M

Rentokil Initial Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 32.76
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For RTO, the sentiment is Negative. The current price of 32.76 is above the 20-day moving average (MA) of 31.29, above the 50-day MA of 31.65, and above the 200-day MA of 27.30, indicating a neutral trend. The MACD of 0.11 indicates Negative momentum. The RSI at 45.60 is Neutral, neither overbought nor oversold. The STOCH value of 26.12 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for RTO.

Rentokil Initial Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
UNF	78 Outperform	$4.53B	21.89	6.45%	0.71%	0.20%	2.72%
ACTG	67 Neutral	$467.91M	16.61	4.02%	―	71.28%	-89.20%
ABM	64 Neutral	$2.19B	17.89	8.80%	2.20%	4.62%	102.72%
Sector *	63 Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%
RTO	60 Neutral	$15.57B	31.57	6.51%	2.20%	1.56%	-32.50%
CBZ	60 Neutral	$1.49B	27.64	6.21%	―	59.19%	-35.47%
BV	59 Neutral	$1.07B	-19.84	2.88%	―	-3.40%	-51.58%

Rentokil Initial Corporate Events

Rentokil Initial Reports Small Reduction in Swedbank Robur Stake

Rentokil Initial disclosed on 23 February 2026 that Swedish asset manager Swedbank Robur Fonder AB has marginally reduced its shareholding in the group. The move, reported via a standard UK TR-1 major holdings notification and filed with the U.S. SEC on Form 6-K, reflects a routine portfolio adjustment rather than a change in control.

Swedbank Robur’s position fell below its previous level, moving to 2.97% of Rentokil Initial’s voting rights, equivalent to 75,055,369 shares as of 19 February 2026. While the stake remains a significant institutional holding, the small decrease may signal ongoing portfolio rebalancing in the stock but does not alter the company’s overall governance structure or trigger any financial instruments-related exposure.

The most recent analyst rating on (RTO) stock is a Hold with a $33.00 price target. To see the full list of analyst forecasts on Rentokil Initial stock, see the RTO Stock Forecast page.

Rentokil Initial Discloses Independent Franchise Partners’ Stake Dip Below 5% Threshold

On 15 January 2026, Independent Franchise Partners LLP marginally reduced its stake in Rentokil Initial plc, taking its holding below the 5% notification threshold to 4.98% of the company’s voting rights, equivalent to 125,795,910 shares, all held via indirect voting rights and with no exposure through financial instruments. The move, formally notified to Rentokil on 16 January and disclosed in a Form 6‑K filed on 19 January, signals only a slight change in the shareholder register but is notable for crossing a key regulatory reporting threshold, offering investors updated visibility on the composition of Rentokil’s institutional investor base and any incremental shifts in governance influence among major shareholders.

The most recent analyst rating on (RTO) stock is a Hold with a $33.00 price target. To see the full list of analyst forecasts on Rentokil Initial stock, see the RTO Stock Forecast page.

BlackRock Lifts Rentokil Initial Stake to 11% of Voting Rights

On 14 January 2026, asset manager BlackRock Inc. increased its stake in Rentokil Initial plc, crossing a major shareholding threshold as defined under UK disclosure rules. The position, notified to the company on 15 January 2026 and disclosed in a January 2026 Form 6-K, shows BlackRock now controls 11.0% of Rentokil’s voting rights in aggregate, up from 10.02%, through a combination of direct shareholdings and various financial instruments, including American Depositary Receipts, securities lending positions and derivatives such as CFDs and ELNs. The move underscores the continued interest of large institutional investors in Rentokil Initial and slightly strengthens BlackRock’s influence among the company’s shareholder base, a development monitored closely by governance-focused stakeholders.

The most recent analyst rating on (RTO) stock is a Hold with a $33.00 price target. To see the full list of analyst forecasts on Rentokil Initial stock, see the RTO Stock Forecast page.

Rentokil Initial Discloses Independent Franchise Partners Crossing 5% Shareholding Threshold

On 14 January 2026, Rentokil Initial plc reported a change in significant shareholding, disclosing that London-based asset manager Independent Franchise Partners LLP had increased its stake in the company. A regulatory filing showed that on 12 January 2026 the investor’s holding rose from 4.9081% to 5.01% of Rentokil Initial’s voting rights, equivalent to 126,470,698 shares, with no additional exposure through financial instruments. Crossing the 5% threshold underscores continuing institutional support for Rentokil Initial and slightly broadens the influence of this shareholder in corporate voting matters, a development that may be closely watched by other investors and governance observers.

The most recent analyst rating on (RTO) stock is a Hold with a $33.00 price target. To see the full list of analyst forecasts on Rentokil Initial stock, see the RTO Stock Forecast page.